We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.85%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$260B
AUM Growth
+$17.6B
Cap. Flow
+$9.95B
Cap. Flow %
3.83%
Top 10 Hldgs %
14.4%
Holding
8,581
New
810
Increased
3,919
Reduced
2,793
Closed
626

Sector Composition

Rank Sector Weight
1 Technology 9.74%
2 Financials 7.41%
3 Healthcare 6.49%
4 Consumer Discretionary 5.87%
5 Industrials 5.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MARPS icon
6826
Marine Petroleum Trust
MARPS
$9.48M
$14K ﹤0.01%
6,151
+3,032
+97% +$7.25K
NERD icon
6827
Roundhill Video Games ETF
NERD
$14.8M
$14K ﹤0.01%
+891
New +$13.8K
NUWE icon
6828
Nuwellis
NUWE
$160K
0
PACK icon
6829
Ranpak Holdings
PACK
$439M
$14K ﹤0.01%
1,598
-1,307
-45% -$13K
PHIO icon
6830
Phio Pharmaceuticals
PHIO
$11.8M
$14K ﹤0.01%
6
+2
+50% +$5.25K
PNC icon
6831
PUT
PNC Financial Services
PNC
$99.7B
$14K ﹤0.01%
+100
New +$13.2K
RAND icon
6832
Rand Capital
RAND
$14K ﹤0.01%
611
-26
-4% -$668
REKR icon
6833
Rekor Systems
REKR
$85.8M
$14K ﹤0.01%
7,307
+6,641
+997% +$6.36K
THM
6834
International Tower Hill Mines
THM
$458M
$14K ﹤0.01%
25,551
+6,568
+35% +$3.26K
TRVI icon
6835
Trevi Therapeutics
TRVI
$2.59B
$14K ﹤0.01%
+1,921
New +$16.5K
UTSL icon
6836
Direxion Daily Utilities Bull 3X ETF
UTSL
$40M
$14K ﹤0.01%
377
-4,028
-91% -$143K
VPC icon
6837
Virtus Private Credit Strategy ETF
VPC
$30.3M
$14K ﹤0.01%
+550
New +$14.2K
VTVT icon
6838
vTv Therapeutics
VTVT
$127M
$14K ﹤0.01%
254
+187
+279% +$11.2K
AIFC
6839
AI Financial Corp
AIFC
$57.6M
$14K ﹤0.01%
3,120
-845
-21% -$3.61K
BIOL
6840
DELISTED
Biolase, Inc.
BIOL
$14K ﹤0.01%
4
UFAB
6841
DELISTED
Unique Fabricating, Inc.
UFAB
$14K ﹤0.01%
5,155
+4,385
+569% +$14.8K
HARP
6842
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$14K ﹤0.01%
+106
New +$12.3K
KSPN
6843
DELISTED
Kaspien Holdings Inc. Common Stock
KSPN
$14K ﹤0.01%
+2,828
New +$18.5K
VYNT
6844
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
$14K ﹤0.01%
563
+561
+28,050% +$17.5K
PAYA
6845
DELISTED
Paya Holdings Inc. Class A Common Stock
PAYA
$14K ﹤0.01%
1,400
+1,300
+1,300% +$12.8K
TMBR
6846
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
$14K ﹤0.01%
38
+35
+1,167% +$27.3K
ZEAL
6847
DELISTED
Zealand Pharma A/S American Depositary Shares
ZEAL
$14K ﹤0.01%
645
-1,762
-73% -$35.6K
MBII
6848
DELISTED
Marrone Bio Innovations, Inc.
MBII
$14K ﹤0.01%
9,470
-21,780
-70% -$33.7K
RESN
6849
DELISTED
Resonant Inc.
RESN
$14K ﹤0.01%
5,845
-1,224
-17% -$3.43K
GSS
6850
DELISTED
Golden Star Resources Ltd.
GSS
$14K ﹤0.01%
3,542
-3,014
-46% -$11.8K

Similar funds

UBS Group's Q2 2019 Portfolio in Review

As of Q2 2019, UBS Group held 8,581 positions worth $260B, up 7.3% from $242B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS Group deployed $9.95B of net new capital in Q2 2019, opening 810 new positions and adding to 3,919 existing holdings. Its largest new stake was Dow Inc: 4,472,376 shares worth $221M.

By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 9.6% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR Bloomberg High Yield Bond ETF, an estimated $377M trimmed.

  • UBS Group's largest Q2 2019 buy was Dow Inc: 4,472,376 shares worth $221M.
  • UBS Group added most to UBS Group in Q2 2019, an estimated $1.59B increase.
  • UBS Group's biggest Q2 2019 reduction was State Street SPDR Bloomberg High Yield Bond ETF, cutting an estimated $377M.
  • UBS Group fully exited Bemis in Q2 2019, selling an estimated $102M.
  • UBS Group's ten largest holdings make up 14% of its $260B portfolio in Q2 2019.
  • UBS Group opened 810 new positions and closed 626 in Q2 2019.
  • UBS Group's portfolio value rose 7.3% quarter-over-quarter to $260B.

Based on UBS Group's 13F filing for Q2 2019, filed 14 Aug 2019.